Skip to main content
Premium Trial:

Request an Annual Quote

Statistically Speaking

Premium

In the five years since Genome Technology’s premier issue, we’ve had 50 faces grace our cover. In that time, we’ve heard all sorts of great rumors, such as: “If you’re on the cover of Genome Technology, you’ll be promoted in six months!” and “If you’re on the cover of Genome Technology, you’ll be out of a job in six months!” We thought it was high time to confront the superstitions — and knowing how our audience likes its data, here’s a breakdown of how the cover models of Genome Technology have fared over the years. In addition to the stats, we offer a few case studies for your review.

 

October 2000

Alan Proctor was on our cover as the head of Pfizer’s Discovery Technology Center near Boston. Within a few years, Proctor had headed to Pfizer’s Connecticut offices to take on the post of vice president of strategic alliances.

 

July 2001

Eric Lander, who appeared as one of our first reader-selected Genome Technology All-Stars, was then director of the Whitehead Institute Center for Genome Research. While his job description hasn’t changed, Lander proved his All-Star status by winning the financial backing of Eli and Edythe Broad, who in mid-2003 pledged to donate or help raise up to $200 million for his center through the next decade. With the money came an official promotion from “center” to “institute” as the Broad Institute was born.

 

March 2004

Kevin McKernan, who appeared on our cover with customer and DFCI faculty Marc Vidal, was co-CSO of Agencourt Bioscience. A little more than a year later, McKernan’s company was acquired by Beckman Coulter in a deal worth as much as $140 million, $100 million of it in cash.

 

Of the people who have appeared on our cover:

8 have left to take jobs with other organizations

4 have been promoted within their organization

2 have seen their companies acquired

1 has won the Nobel Prize

 

Total people shown on cover: 50

Our cover models hailed from:

Pharma/biotech 18

Academia 20

Government 7

Other 5

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.